Cochrane Abstracts
Dexmedetomidine for the management of awake fibreoptic intubation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dexmedetomidine for the Management of Awake Fibreoptic Intubation." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438963/all/Dexmedetomidine_for_the_management_of_awake_fibreoptic_intubation.
Dexmedetomidine for the management of awake fibreoptic intubation. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438963/all/Dexmedetomidine_for_the_management_of_awake_fibreoptic_intubation. Accessed March 24, 2025.
Dexmedetomidine for the management of awake fibreoptic intubation. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438963/all/Dexmedetomidine_for_the_management_of_awake_fibreoptic_intubation
Dexmedetomidine for the Management of Awake Fibreoptic Intubation [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438963/all/Dexmedetomidine_for_the_management_of_awake_fibreoptic_intubation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dexmedetomidine for the management of awake fibreoptic intubation
ID - 438963
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438963/all/Dexmedetomidine_for_the_management_of_awake_fibreoptic_intubation
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
